These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 8071866
1. A new endothelin receptor antagonist, TAK-044, shows long-lasting inhibition of both ETA- and ETB-mediated blood pressure responses in rats. Ikeda S, Awane Y, Kusumoto K, Wakimasu M, Watanabe T, Fujino M. J Pharmacol Exp Ther; 1994 Aug; 270(2):728-33. PubMed ID: 8071866 [Abstract] [Full Text] [Related]
2. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists. Awane-Igata Y, Ikeda S, Watanabe T. Br J Pharmacol; 1997 Feb; 120(3):516-22. PubMed ID: 9031758 [Abstract] [Full Text] [Related]
3. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats. Gardiner SM, Kemp PA, March JE, Bennett T, Davenport AP, Edvinsson L. Br J Pharmacol; 1994 Jun; 112(2):477-86. PubMed ID: 8075866 [Abstract] [Full Text] [Related]
4. Sarafotoxin S6c elicits a non-ETA or non-ETB-mediated pressor response in the pithed rat. Flynn DA, Sargent CA, Brazdil R, Brown TJ, Roach AG. J Cardiovasc Pharmacol; 1995 Jun; 26 Suppl 3():S219-21. PubMed ID: 8587368 [Abstract] [Full Text] [Related]
5. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney. Wellings RP, Corder R, Warner TD, Cristol JP, Thiemermann C, Vane JR. Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396 [Abstract] [Full Text] [Related]
8. Characterization of receptors mediating vascular responses to endothelin-1 in the conscious rat. Filep JG, Clozel M, Fournier A, Földes-Filep E. Br J Pharmacol; 1994 Nov; 113(3):845-52. PubMed ID: 7858876 [Abstract] [Full Text] [Related]
12. Hyperresponsiveness to ET-1 after treatment with a mixture of ETA and ETB receptor antagonists in the rabbit in vivo and in vitro. D'Orléans-Juste P, Yano M, Maurice MC, Gratton JP. J Cardiovasc Pharmacol; 1995 Nov; 26 Suppl 3():S369-72. PubMed ID: 8587417 [Abstract] [Full Text] [Related]
13. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats. Matsuura T, Miura K, Ebara T, Yukimura T, Yamanaka S, Kim S, Iwao H. Br J Pharmacol; 1997 Sep; 122(1):81-6. PubMed ID: 9298531 [Abstract] [Full Text] [Related]
14. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney. Pollock DM, Opgenorth TJ. Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752 [Abstract] [Full Text] [Related]
16. Endothelin-B receptor-dependent modulation of the pressor and prostacyclin-releasing properties of dynamically converted big endothelin-1 in the anesthetized rabbit. Gratton JP, Cournoyer G, D'Orléans-Juste P. J Cardiovasc Pharmacol; 1998 Mar; 31 Suppl 1():S161-3. PubMed ID: 9595427 [Abstract] [Full Text] [Related]
19. Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats. Watanabe T, Awane Y, Ikeda S, Fujiwara S, Kubo K, Kikuchi T, Kusumoto K, Wakimasu M, Fujino M. Br J Pharmacol; 1995 Mar; 114(5):949-54. PubMed ID: 7780649 [Abstract] [Full Text] [Related]
20. Implication of different endothelin receptors in the vascular action of a hypertensive dose of ET-1 in rat. Cornet S, Pirotzky E, Braquet P. J Cardiovasc Pharmacol; 1993 Mar; 22 Suppl 8():S239-42. PubMed ID: 7509955 [Abstract] [Full Text] [Related] Page: [Next] [New Search]